Skip to main content

Revolution Medicines, Inc.

RVMDW
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001628171

In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $93.0M in total; no superinvestor holds it.

Other share classesRVMD

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Revolution Medicines, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
17 filings
10 insiders, $77.6M in total
Insiders trading
10
Net value
−$77.6M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Revolution Medicines, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Revolution Medicines, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Mancini AnthonySee Remarks39,765Sep 28, 20268
Anderson Elizabeth MDirector4,333Sep 24, 20263
Sandler Alan B.Chief Development Officer52,868Sep 18, 20261
Kelsey Stephen MichaelSee Remarks286,307Sep 18, 20267
Horn Margaret AChief Operating Officer149,680Sep 18, 20267
Goldsmith Mark ASee Remarks253,342Sep 18, 202613
Cislini JeffSVP & General Counsel52,541Sep 18, 20269
Anders JackChief Financial Officer119,216Sep 18, 20269
Kim Lorence H.Director0IndirectSep 10, 20263
Patel SushilDirector21,656Jul 1, 20262
Borisy AlexisDirector2,340,075Jun 23, 20261
Horning SandraDirector97,765Jun 23, 20261
Clyburn FrankDirector10,929Jun 23, 20261
Borellini FlaviaDirector26,215Jun 23, 20261
Wang XiaolinSee Remarks116,063Mar 19, 20262
Wei LinChief Medical Officer101,366Mar 19, 20262
Schroeder ThiloDirector760,869IndirectDec 9, 20240
Weber BarbaraDirector13,065Oct 10, 20240
Schmidt Eric ThomasDirector21,251Jun 12, 20230
Exter NeilDirector28,815Jun 17, 20220
Tepper Robert I10% Owner5,104,130Jun 10, 20220
Third Rock Ventures III, L.P.10% Owner5,104,130Jun 10, 20220
TRV GP III, LLC10% Owner5,104,130Jun 10, 20220
Third Rock Ventures GP III, L.P.10% Owner5,104,130Jun 10, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2024 (view filing)Sep 162 daysAnders JackChief Financial OfficerSSale−2.24K$44.19−$99.2K−2.2%98.9K after10b5-1
Sep 18, 2024 (view filing)Sep 162 daysGoldsmith Mark ASee RemarksSSale−11.7K$44.19−$517.7K−3.8%300.2K after10b5-1
Sep 18, 2024 (view filing)Sep 162 daysHorn Margaret AChief Operating OfficerSSale−4.33K$44.19−$191.4K−3.2%132.3K after10b5-1
Sep 18, 2024 (view filing)Sep 162 daysKelsey Stephen MichaelSee RemarksSSale−4.67K$44.19−$206.1K−1.7%264.4K after10b5-1
Sep 18, 2024 (view filing)Sep 162 daysCislini JeffGeneral CounselSSale−1.45K$44.19−$64.3K−3.1%45.6K after10b5-1
Sep 16, 2024 (view filing)Sep 133 daysKelsey Stephen MichaelSee RemarksSSale−16.7K$43.33−$722.1K−5.8%269.1K after2 lots10b5-1
Aug 15, 2024 (view filing)Aug 132 daysKelsey Stephen MichaelSee RemarksSSale−16.7K$42.98−$716.3K−5.8%269.1K after10b5-1
Aug 2, 2024 (view filing)Aug 11 dayGoldsmith Mark ASee RemarksSSale−10.0K$45.88−$458.8K−3.1%311.9K after2 lots10b5-1
Jul 17, 2024 (view filing)Jul 152 daysKelsey Stephen MichaelSee RemarksSSale−16.7K$46.47−$774.5K−5.8%269.1K after5 lots10b5-1
Jul 16, 2024 (view filing)Jul 124 daysGoldsmith Mark ASee RemarksSSale−25.0K$45.05−$1.13M−7.4%311.9K after10b5-1
Jul 16, 2024 (view filing)Jul 124 daysGoldsmith Mark ASee RemarksSSale−10.0K$45.01−$450.1K−28.2%25.4K after2 lots10b5-1
Jul 10, 2024 (view filing)Jul 91 dayCislini JeffGeneral CounselSSale−2.40K$40.83−$98.0K−4.8%47.1K after10b5-1
Jul 10, 2024 (view filing)Jul 91 dayPatel SushilDirectorSSale−2.15K$44.00−$94.8K−9.7%19.9K after10b5-1
Jun 27, 2024 (view filing)Jun 261 dayCislini JeffGeneral CounselSSale−2.00K$38.47−$76.9K−3.9%49.5K after10b5-1
Jun 26, 2024 (view filing)Jun 24-252 daysKelsey Stephen MichaelSee RemarksSSale−16.7K$39.06−$651.0K−5.8%269.1K after2 lots10b5-1
Jun 20, 2024 (view filing)Jun 173 daysGoldsmith Mark ASee RemarksSSale−11.9K$37.39−$446.8K−3.7%311.9K after10b5-1
Jun 20, 2024 (view filing)Jun 173 daysAnders JackChief Financial OfficerSSale−1.89K$37.39−$70.8K−1.8%101.2K after10b5-1
Jun 20, 2024 (view filing)Jun 173 daysHorn Margaret AChief Operating OfficerSSale−4.42K$37.39−$165.1K−3.1%136.7K after10b5-1
Jun 20, 2024 (view filing)Jun 173 daysKelsey Stephen MichaelSee RemarksSSale−3.35K$37.39−$125.2K−1.2%269.1K after10b5-1
Jun 20, 2024 (view filing)Jun 173 daysCislini JeffGeneral CounselSSale−1.76K$37.39−$65.7K−3.3%51.5K after10b5-1
Jun 20, 2024 (view filing)Jun 173 daysWei LinChief Medical OfficerSSale−5.59K$37.39−$209.0K−7.3%70.9K after
Jun 5, 2024 (view filing)Jun 32 daysGoldsmith Mark ASee RemarksSSale−7.50K$39.99−$300.0K−2.3%322.3K after3 lots10b5-1
May 22, 2024 (view filing)May 211 dayCislini JeffGeneral CounselSSale−1.50K$39.12−$58.7K−2.8%52.9K after2 lots10b5-1
May 3, 2024 (view filing)May 3Same dayAnders JackChief Financial OfficerSSale−10.0K$40.03−$400.3K−8.9%102.0K after10b5-1
Apr 12, 2024 (view filing)Apr 102 daysGoldsmith Mark ASee RemarksSSale−7.50K$35.48−$266.1K−1.6%452.9K after10b5-1
Apr 12, 2024 (view filing)Apr 102 daysGoldsmith Mark ASee RemarksSSale−10.0K$35.34−$353.4K−24.7%30.4K after2 lots10b5-1
Apr 12, 2024 (view filing)Apr 102 daysPatel SushilDirectorSSale−2.15K$37.00−$79.7K−12.1%15.7K after10b5-1
Mar 28, 2024 (view filing)Mar 271 dayCislini JeffGeneral CounselSSale−1.50K$30.99−$46.5K−2.7%54.4K after2 lots10b5-1
Mar 20, 2024 (view filing)Mar 182 daysCislini JeffGeneral CounselSSale−1.25K$31.58−$39.5K−2.2%55.9K after10b5-1
Mar 20, 2024 (view filing)Mar 182 daysKelsey Stephen MichaelSee RemarksSSale−2.12K$31.58−$67.0K−0.8%270.9K after10b5-1
Mar 20, 2024 (view filing)Mar 182 daysHorn Margaret AChief Operating OfficerSSale−2.91K$31.58−$92.0K−2.0%139.6K after10b5-1
Mar 20, 2024 (view filing)Mar 182 daysGoldsmith Mark ASee RemarksSSale−5.79K$31.58−$182.8K−1.2%460.4K after10b5-1
Mar 20, 2024 (view filing)Mar 182 daysAnders JackChief Financial OfficerSSale−1.26K$31.58−$39.8K−1.2%102.0K after10b5-1
Mar 13, 2024 (view filing)Mar 11-122 daysHorn Margaret AChief Operating OfficerSSale−23.7K$34.04−$805.7K−14.2%142.5K after2 lots10b5-1
Jan 24, 2024 (view filing)Jan 222 daysCislini JeffGeneral CounselSSale−1.50K$27.00−$40.5K−4.0%36.1K after10b5-1
Jan 10, 2024 (view filing)Jan 82 daysKelsey Stephen MichaelSee RemarksSSale−3.34K$29.01−$96.8K−1.5%221.6K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysKelsey Stephen MichaelSee RemarksSSale−13.3K$29.10−$387.9K−5.6%225.0K after10b5-1
Dec 29, 2023 (view filing)Dec 272 daysKelsey Stephen MichaelSee RemarksSSale−33.3K$29.01−$967.0K−12.3%238.3K after10b5-1
Dec 20, 2023 (view filing)Dec 182 daysAnders JackChief Financial OfficerSSale−1.77K$25.90−$46.0K−2.3%76.4K after10b5-1
Dec 20, 2023 (view filing)Dec 182 daysGoldsmith Mark ASee RemarksSSale−8.16K$25.90−$211.5K−2.1%376.2K after10b5-1
Dec 20, 2023 (view filing)Dec 182 daysCislini JeffGeneral CounselSSale−1.23K$25.90−$31.8K−3.2%37.3K after10b5-1
Dec 20, 2023 (view filing)Dec 182 daysKelsey Stephen MichaelSee RemarksSSale−2.09K$25.90−$54.1K−0.8%271.6K after10b5-1
Dec 19, 2023 (view filing)Dec 15-184 daysHorn Margaret AChief Operating OfficerSSale−7.99K$26.36−$210.7K−7.3%101.5K after2 lots10b5-1
Dec 8, 2023 (view filing)Dec 62 daysHorn Margaret AChief Operating OfficerSSale−5.00K$25.00−$125.0K−4.6%104.5K after10b5-1
Nov 20, 2023 (view filing)Nov 20Same dayCislini JeffGeneral CounselSSale−1.50K$21.70−$32.5K−3.7%38.5K after10b5-1
Oct 18, 2023 (view filing)Oct 162 daysHorn Margaret AChief Operating OfficerSSale−25.0K$33.95−$848.8K−20.5%97.0K after5 lots10b5-1
Oct 13, 2023 (view filing)Oct 112 daysKelsey Stephen MichaelSee RemarksSSale−16.7K$29.05−$484.2K−5.7%273.7K after10b5-1
Oct 2, 2023 (view filing)Sep 284 daysCislini JeffGeneral CounselSSale−2.00K$28.20−$56.4K−4.8%40.0K after2 lots10b5-1
Sep 20, 2023 (view filing)Sep 182 daysKelsey Stephen MichaelSee RemarksSSale−2.06K$31.31−$64.5K−0.7%290.4K after
Sep 20, 2023 (view filing)Sep 182 daysGoldsmith Mark ASee RemarksSSale−8.05K$31.31−$252.2K−2.3%349.3K after